Author Affiliations: Ocular Oncology Service, Wills Eye Institute (Drs Patel and Shields and Ms Murphy), and Department of Ophthalmology, University of Pennsylvania School of Medicine (Dr Patel), Philadelphia.
A 31-month-old Hispanic boy presented for evaluation of possible retinoblastoma in the right eye. At 22 months of age, strabismus had developed. There was no history of trauma. Three months later, examination showed total retinal detachment with the retina visible immediately posterior to the lens (Figure, A and B). Visual acuity was reduced to light perception in the right eye. With the left eye, he could fix and follow an object normally. The anterior segment of the right eye was unremarkable except for xanthocoria (yellow pupil) from an exudative retinal detachment. Examination of the left eye was unremarkable. He was treated with anterior chamber injections of bevacizumab on a monthly basis for 5 months to resolve the retinal detachment.
Figure. A, External view of the patient at initial presentation. B, Close-up view of the right eye showing the detached retina visible immediately posterior to the lens through a dilated pupil. The inferior retina shows telangiectatic retinal vessels characteristic of this condition. The detached retina appears yellow because of the presence of lipid exudate below the retina. C, External view of the patient 6 months later. D, Close-up view of the right eye at the 6-month follow-up showing numerous refractile cholesterol crystals in the anterior chamber.
Following the injections, visual acuity was unchanged. Intraocular pressures were normal in each eye (13 mm Hg). No conjunctival hyperemia or corneal opacity was seen. The anterior segment of the right eye was filled with refractile yellow crystals (Figure, C and D). There was no view of the fundus but B-scan ultrasonography revealed total retinal detachment with a retinal macrocyst. There was no intraocular tumor or calcification.
What is your diagnosis?
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.